Benign Breast Disease - Molecular Differentiation of Risk

Worsham, Maria J.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 1R01CA070923-01
• Application #: 2009822
• Study Section: Epidemiology and Disease Control Subcommittee 2 (EDC)
• Project Start: 1996-09-30
• Project End: 2001-09-29
• Budget Start: 1996-09-30
• Budget End: 1997-09-29
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: Henry Ford Health System
• Department: Genetics
• Type: Schools of Medicine
• DUNS #: 073134603
• City: Detroit
• State: MI
• Country: United States
• Zip Code: 48202

Publications

Chen, Kang Mei; Stephen, Josena K; Raju, Usha et al. (2011) Delineating an epigenetic continuum for initiation, transformation and progression to breast cancer. Cancers (Basel) 3:1580-92

Worsham, Maria J; Raju, Usha; Lu, Mei et al. (2009) Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat 118:1-7

Worsham, Maria J; Abrams, Judith; Raju, Usha et al. (2007) Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J 13:115-21

Raju, Usha; Lu, Mei; Sethi, Seema et al. (2006) MOLECULAR CLASSIFICATION OF BREAST CARCINOMA IN SITU. Curr Genomics 7:523-532

Natarajan, Girija; Johnson, Yvette R; Zhang, Fan et al. (2006) Real-time polymerase chain reaction for the rapid detection of group B streptococcal colonization in neonates. Pediatrics 118:14-22

Worsham, Maria J; Pals, Gerard; Schouten, Jan P et al. (2003) Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129:702-8

Barnabas, Nandita; Amin, Mitual B; Pindolia, Kirit et al. (2002) Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma. J Surg Oncol 80:52-60

Worsham, Maria J; Pals, Gerard; Raju, Usha et al. (2002) Establishing a molecular continuum in breast cancer DNA microarrays and benign breast disease. Cytometry 47:56-9

Mao, H; Liu, H; Fu, X et al. (2001) Loss of nm23 expression predicts distal metastases and poorer survival for breast cancer. Int J Oncol 18:587-91

Pals, G; Young, C; Mao, H S et al. (2001) Detection of a single base substitution in a single cell using the LightCycler. J Biochem Biophys Methods 47:121-9